Navigation Links
ResMed's New Nasal Pillows System is Our Quietest Yet; Ultra-light AirFit P10 Packs Powerful Performance in Just over 1.5 Ounces
Date:1/13/2014

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) continues its 25-year history of innovating powerful and comfortable solutions for treating sleep-disordered breathing with today's introduction of the ultra-light, ultra-quiet ResMed AirFit™ P10 nasal pillows system.

(Photo:  http://photos.prnewswire.com/prnh/20140113/LA44444-a)

(Photo:  http://photos.prnewswire.com/prnh/20140113/LA44444-b)

(Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The AirFit P10 weighs just 1.6 ounces, and has only three parts, including a new soft and stable QuickFit™ headgear. ResMed has pioneered a new mesh vent called QuietAir™ so the AirFit P10 is 50 percent quieter than its predecessor, diffusing air with minimal disturbance to patients or their bed partners. ResMed's AirFit P10 maintains a secure seal while delivering a high level of facial freedom.

"The AirFit P10's light weight and ultra-quiet performance also translates directly into better compliance," said Jon Yerbury, vice president of ResMed's Sleep-Disordered Breathing Strategic Business Unit. "Our internal research has shown that the AirFit P10 provides an average of 40 more minutes of sleep per night than ResMed's current market-leading nasal pillows mask."

For the convenience of ResMed's home medical equipment provider customers as well as patients, the AirFit P10 has color-coded cushion sizing, with small, medium and large sizes in the standard AirFit P10 system, and extra-small, small and medium sizes in the AirFit For Her system, which features headgear designed for women.

ResMed's AirFit P10 begins shipping in the U.S. today.

About ResMed: ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com. Contacts:For News MediaFor InvestorsGretchen Griswold

David PendarvisDirector, Global Corporate Communications

Chief Administrative Officer and GlobalO: 858-836-6789

General Counselnews@resmed.com

O: 858-836-5983David.Pendarvis@ResMed.com


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment
2. Systematic Review Finds Intranasal Midazolam Comparable To Intravenous Or Rectal Administration Of Diazepam For Treatment Of Acute Seizure Emergencies In Pediatric Patients
3. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
4. Considering Corticosteroid Nasal Sprays
5. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
6. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
7. Aegis Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
8. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
9. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society
10. Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landsc
11. US Intranasal Drug Delivery Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... SPRING, Md. , Dec. 2, 2016 ... new indication for Jardiance (empagliflozin) to reduce the risk ... diabetes mellitus and cardiovascular disease. "Cardiovascular ... with type 2 diabetes mellitus," said Jean-Marc Guettier ... and Endocrinology Products in FDA,s Center for Drug Evaluation ...
(Date:12/2/2016)... , December 2, 2016 ... global cardiac pacemaker market in its upcoming report titled, "Global Market Study ... a Declining CAGR of -1.4% between 2016 and 2024". The ... Mn in 2015 and this is likely to decline ... revenue, the global cardiac pacemaker market is anticipated to ...
(Date:12/2/2016)... , December 2, 2016 According to ... "Global Market Study on Automated Endoscope Reprocessors: Single Basin Automated ... of 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors ... expected to expand at a CAGR of 7.2% during an ... US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest ... patients, standing as living proof that attitude and determination can combine into the ... that spike around the holidays. This campaign will offer patients a new-found hope, ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd ... Beach Resort and Spa in Honolulu, offering local frontline clinicians the opportunity to ... , The demand for supplemental training related to pain management has surged ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 ... to create versatile lower third titles with just a few clicks of the mouse," ... 2 includes 30 lower third animations. Choose from various styles with accented animations, rigid ...
(Date:12/2/2016)... Miami, FL (PRWEB) , ... December 02, 2016 , ... ... they are winners of $1,000 each from the National Family Partnership and the Drug ... winning families who decorated their homes and the 10 winning schools who decorated their ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... treatment has announced the opening of a new eating disorder treatment center location ... outpatient treatment for adults and adolescents, both males and females ages 10 and ...
Breaking Medicine News(10 mins):